Study suggests new treatments for jaw tumors
Nature Genetics
May 26, 2014
Two genes linked to ameloblastomas, tumors of the jaw, are reported in a paper published online this week in Nature Genetics. The results suggest promising treatment options for these destructive jaw tumors.
Ameloblastomas are rare, benign tumors that often lead to facial disfigurement. Robert West and colleagues identified two genes, SMO and BRAF, that are often mutated in ameloblastomas. In their samples, tumors of the upper jaw tended to have SMO mutations, whereas the lower jaw tumors tended to have BRAF mutations. For each gene, the researchers identified an FDA-approved drug that can inhibit the mutant form in human cells. More testing is needed to see if these drugs can help ameloblastoma patients.
doi: 10.1038/ng.2986
Research highlights
-
Jul 1
Criminology: Predicting police enforcement bias in major US citiesNature Human Behaviour
-
Jul 1
Evolution: Pandas gave bamboo the thumbs up at least six million years agoScientific Reports
-
Jul 1
Space health: The path of most resistance could help limit bone loss during spaceflightScientific Reports
-
Jun 30
Genomics: Gray wolf genome hints at dual ancestry of dogsNature
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 30
Microbiology: Transmission of gastrointestinal viruses in salivaNature